| NSC | Compound | Enrichment | Correlation |
|---|---|---|---|
| NSC 684836 | Butanamide, N-[2-[(4-fluorophenyl)amino]-1,1,1,3,3,3- hexafluoro-2-propyl]- | 0.0102962192514438 | 0.42514107 |
| NSC 685687 | 1,2,5,6,9-Pentaazadicylopent[a,b]indene-3,4(2H,5H)-dione,2,5-diphenyl- | 0.0102962192514438 | 0.38228025 |
| NSC 696990 | Null | 0.0102962192514438 | 0.51460468 |
| NSC 711611 | Null | 0.0102962192514438 | 0.49257961 |
| NSC 716089 | Null | 0.0102962192514438 | 0.32548713 |
| NSC 736164 | pyrazoline derivative | 0.0102962192514438 | 0.32141892 |
| NSC 749550 | 3-amino-N-(4-benzylphenyl)-5-chloro-1H-indazole-1-carboxamide | 0.0102962192514438 | 0.18768548 |
| NSC 128571 | Ethanesulfonic acid, compd. with 2-chloro-5-[4-[2-chloro-4-(4,6-diamino-2,2-dimethyl-s-triazin-1(2H)-yl)phenyl]butyl]benzenesulfonyl fluoride (1:1) (8CI) | 0.0102962192514439 | 0.4686388 |
| NSC 667924 | Null | 0.0107933723273943 | 0.32971113 |
| NSC 684480 | 7H-Pyrido[3,2-d][1]benzazepin-6-one, 2-(3-chlorophenyl)- 5,6-dihydro-4-phenyl- | 0.0107933723273943 | -0.42307405 |